Alembic Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 15,949.3 million compared to INR 14,750.1 million a year ago. Revenue was INR 16,050.8 million compared to INR 14,753.4 million a year ago. Net income was INR 1,365.6 million compared to INR 1,333.5 million a year ago. Basic earnings per share from continuing operations was INR 6.95 compared to INR 6.78 a year ago.
For the six months, sales was INR 30,810.8 million compared to INR 27,371.5 million a year ago. Revenue was INR 31,029 million compared to INR 27,385.7 million a year ago. Net income was INR 2,571.6 million compared to INR 674.7 million a year ago. Basic earnings per share from continuing operations was INR 13.08 compared to INR 3.43 a year ago.